Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Kite Pharma Inc.
Sponsor

Kite Pharma Inc.

United States 2400 Broadway, 90404-3030, United States

About the sponsor

Kite Pharma Inc. focuses extensively on relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, indolent non-Hodgkin lymphoma, mantle cell lymphoma, marginal zone lymphoma, Burkitt lymphoma, and Richter transformation.

  • Relapsed/refractory B-cell non-Hodgkin lymphoma
  • First-line high-risk large B-cell lymphoma
  • Follicular lymphoma
  • Rare B-cell malignancies

The portfolio also includes studies in Waldenstrom macroglobulinemia and hairy cell leukemia, reflecting a strong interest in difficult-to-treat mature B-cell disorders.

About Specializations

Kite Pharma Inc. runs clinical trials in conditions such as Follicular lymphoma, Haematological malignancy, Plasma cell myeloma refractory, Non-Hodgkin's lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

11 clinical trials

Haematological malignancy

Recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Axicabtagene Ciloleucel
  • Sponsor:Kite Pharma Inc.

Plasma cell myeloma refractory

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Kite Pharma Inc.

Follicular lymphoma

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Kite Pharma Inc.

Non-Hodgkin's lymphoma+2

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Brexucabtagene Autoleucel
  • Sponsor:Kite Pharma Inc.

Follicular lymphoma+2

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ammonium Chloride Bp
  • Sponsor:Kite Pharma Inc.

Mantle cell lymphoma refractory

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Kite Pharma Inc.

Burkitt's lymphoma+1

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Kite Pharma Inc.

Hairy cell leukaemia

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Mesna
  • Sponsor:Kite Pharma Inc.

Richter's syndrome

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Kite Pharma Inc.

Waldenstrom's macroglobulinaemia+1

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Kite Pharma Inc.

Diffuse large B-cell lymphoma

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Kite Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.